In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site

European Journal of Immunology

Volumn 41, Issue 3, 2011, Pages 749-759

  Haverkamp, Jessica M ^a,b   Crist, Scott A ^b,c   Elzey, Bennett D ^b,c   Cimen, Cansu ^b   Ratliff, Timothy L ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Purdue University   (United States)

Author keywords

Immune regulation; Inflammation; Myeloid derived suppressor cells; Prostate inflammation

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; IMMUNOREGULATION; IN VIVO STUDY; INFLAMMATION; LIVER; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; SPLEEN; SUPPRESSOR CELL; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; ARGINASE; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MYELOID CELLS; NITRIC OXIDE SYNTHASE TYPE II; OVALBUMIN; PHENOTYPE; PROSTATITIS; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 79951793550     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041069     Document Type: Article

References (38)

1. Bronte, V. and Zanovello, P., Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol. 2005. 5: 641-654.
2. Gabrilovich, D. I. and Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 2009. 9: 162-174.
3. Ilkovitch, D. and Lopez, D. M., The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. Cancer Res. 2009. 69: 5514-5521.
4. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P. and Van Ginderachter, J. A., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008. 111: 4233-4244.
5. Youn, J. I., Nagaraj, S., Collazo, M. and Gabrilovich, D. I., Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 2008. 181: 5791-5802.
6. De Santo, C., Salio, M., Masri, S. H., Lee, L. Y., Dong, T., Speak, A. O., Porubsky, S. et al., Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 2008. 118: 4036-4048.
7. Kusmartsev, S. and Gabrilovich, D. I., STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 2005. 174: 4880-4891.
8. Greifenberg, V., Ribechini, E., Rossner, S. and Lutz, M. B., Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur. J. Immunol. 2009. 39: 2865-2876.
9. Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L. et al., Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. J. Exp. Med. 2006. 203: 2691-2702.
10. Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L. X., Cohen, P. A. and Shu, S., Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodes. J. Immunol. 2008. 181: 3291-3300.
11. Bunt, S. K., Sinha, P., Clements, V. K., Leips, J. and Ostrand-Rosenberg, S., Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol. 2006. 176: 284-290.
12. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M. et al., Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 2010. 40: 22-35.
13. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia, K. M., O'Malley, K. A. et al., MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J. Exp. Med. 2007. 204: 1463-1474.
14. Marhaba, R., Vitacolonna, M., Hildebrand, D., Baniyash, M., Freyschmidt-Paul, P. and Zoller, M., The importance of myeloid-derived suppressor cells in the regulation of autoimmune effector cells by a chronic contact eczema. J. Immunol. 2007. 179: 5071-5081.
15. Lees, J. R., Charbonneau, B., Hayball, J. D., Diener, K., Brown, M., Matusik, R., Cohen, M. B. and Ratliff, T. L., T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate 2006. 66: 578-590.
16. Vykhovanets, E. V., Resnick, M. I., MacLennan, G. T. and Gupta, S., Experimental rodent models of prostatitis: limitations and potential. Prostate Cancer Prostatic Dis. 2007. 10: 15-29.
17. Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S. et al., Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010. 32: 790-802.
18. Pauleau, A. L., Rutschman, R., Lang, R., Pernis, A., Watowich, S. S. and Murray, P. J., Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 2004. 172: 7565-7573.
19. Teng, X., Li, D., Catravas, J. D. and Johns, R. A., C/EBP-beta mediates iNOS induction by hypoxia in rat pulmonary microvascular smooth muscle cells. Circ. Res. 2002. 90: 125-127.
20. Souza, J. M., Peluffo, G. and Radi, R., Protein tyrosine nitration - functional alteration or just a biomarker? Free Radic. Biol. Med. 2008. 45: 357-366.
21. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2001. 2: 907-916.
22. Aktan, F., iNOS-mediated nitric oxide production and its regulation. Life Sci. 2004. 75: 639-653.
23. Wu, G. and Morris Jr S. M., Arginine metabolism: nitric oxide and beyond. Biochem. J. 1998. 336: 1-17.
24. Tenu, J. P., Lepoivre, M., Moali, C., Brollo, M., Mansuy, D. and Boucher, J. L., Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide 1999. 3: 427-438.
25. Reif, D. W. and McCreedy, S. A., N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitric oxide synthases. Arch. Biochem. Biophys. 1995. 320: 170-176.
26. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya, T. et al., Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J. Immunol. 2009. 182: 5693-5701.
27. Kusmartsev, S. A., Li, Y. and Chen, S. H., Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 2000. 165: 779-785.
28. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Basso, G. et al., Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J. Clin. Invest. 2006. 116: 2777-2790.
29. Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K. and Khoury, S. J., CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J. Immunol. 2007. 179: 5228-5237.
30. Munder, M., Eichmann, K., Moran, J. M., Centeno, F., Soler, G. and Modolell, M., Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J. Immunol. 1999. 163: 3771-3777.
31. Coccia, E. M., Stellacci, E., Marziali, G., Weiss, G. and Battistini, A., IFN-gamma and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation. Int. Immunol. 2000. 12: 977-985.
32. Pekarek, L. A., Starr, B. A., Toledano, A. Y. and Schreiber, H., Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 1995. 181: 435-440.
33. Tvinnereim, A. R., Hamilton, S. E. and Harty, J. T., Neutrophil involvement in cross-priming CD8+ T cell responses to bacterial antigens. J. Immunol. 2004. 173: 1994-2002.
34. Matsuzaki, J., Tsuji, T., Chamoto, K., Takeshima, T., Sendo, F. and Nishimura, T., Successful elimination of memory-type CD8+ T cell subsets by the administration of anti-Gr-1 monoclonal antibody in vivo. Cell Immunol. 2003. 224: 98-105.
35. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I. et al., HIF-1{alpha} regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 2010. 207: 2439-2453.
36. Griendling, K. K., Sorescu, D., Lassegue, B. and Ushio-Fukai, M., Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 2000. 20: 2175-2183.
37. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S. and Srikrishna, G., Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J. Immunol. 2008. 181: 4666-4675.
38. Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P. and Zanovello, P., Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 2000. 96: 3838-3846.